The leap people make here is: if BPC-157 helps inflammatory bowel disease and ulcers in rats, maybe it helps IBS or leaky gut in humans
"But you're going to have high responders who lose up to 35 percent." And if youre eating a lot less, you may not be getting the ideal balance of nutrients, which can cause telogen effluvium, especially in the case of decreased protein intake or zinc deficiency, research shows
Cost-Effectiveness of GLP-1 RAs Versus Other Medication Classes in Europe Cost-effectiveness of GLP-1 RAs versus other medication classes undoubtedly makes an impact on the prescribing behaviour
Thus, these BPC 157 effects may reveal an intriguing point in that BPC 157 therapy seemed to overwhelm electrolyte disturbances (including muscle disabilities) in rats [19,55,80,105,106] as part of its cytoprotective effect on the tissue target(s) (for review, see [1,3,4,5,6,8,9,32,33,34,92])